Vensana Capital is a venture capital and growth equity firm that invests in development- and commercial-stage companies across the medtech sector. Their strategy involves providing capital and partnership to entrepreneurs innovating in areas such as medical devices, diagnostics and data science, drug delivery, digital health, life-science tools, and tech-enabled services.
Portfolio
4
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Ventaris Surgical, Inc. | Series A | $30M | Jan 2026 |
| Okami Medical | Series B | $32.5M | Oct 2024 |
| Nyra Medical, Inc. | Series A | $20M | Nov 2022 |
| Cleerly Coronary | Series B | $43M | Jun 2021 |
Top Co-Investors
Broadview Ventures1 shared
U.S. Venture Partners1 shared
New Leaf Venture Partners1 shared
DigiTx Partners1 shared
Cigna Ventures1 shared
Longitude Capital1 shared
Atypical1 shared
Neotribe1 shared
Boutique Venture Partners1 shared
Last updated: 3 March 2026